All In Biotech

Drug Trial Radar · NCT00477490

Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia

A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multi-Center Study With a Double Blind Extension Investigating the Efficacy and Safety of a Fast- Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults

Last checked: Nov 19, 2026Latest source record: Nov 2, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 799 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

799

Actual

Start

May 2007

Primary completion

Feb 2008

Study completion Feb 2008

Sponsor

Lead sponsor
Ferring PharmaceuticalsIndustry
Sponsor type
Industry
First posted
May 23, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the efficacy and safety of several doses of the melt formulation of desmopressin in a broad population of adult patients with nocturia.

Conditions

  • Nocturia

Interventions

  • desmopressin acetateDrug

    Oral lyophilisate of desmopressin acetate placed under the participant's tongue, without water, once daily approximately 1 hour before bedtime in the assigned dosage: 10, 25, 50 or 100 μg

  • PlaceboDrug

    Oral placebo placed under the participant's tongue, without water, once daily approximately 1 hour before bedtime.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part I: Change From Baseline in Mean Number of Nocturnal Voids at Week 4Time frame: - Week 3 to Day 1 (Baseline), Week 4 (end of Part I)
  2. Part I: Percentage of Participants With Greater Than 33 Percent Reduction From Baseline in Mean Number of Nocturnal Voids at Week 4Time frame: - Week 3 to Day 1 (Baseline), Week 4 (end of Part I)

Locations

80 sites in 2 countries. Site status is shown where the registry gives one.

  • Radiant Research

    Birmingham, Alabama

  • Radiant Research

    Scottsdale, Arizona

  • Arkansas Primary Care Clinic

    Little Rock, Arkansas

  • Advanced Urology Medical Center

    Anaheim, California

  • Impact Clinical Trials

    Beverly Hills, California

  • Atlantic Urology Medical Group

    Long Beach, California

  • California Professional Research

    Newport Beach, California

  • San Diego Uro-Research

    San Diego, California

  • Radiant Research

    Santa Rosa, California

  • West Coast Clinical Research

    Tarzana, California

  • Western Clinical Research

    Torrance, California

  • Urology Associates PC

    Denver, Colorado

  • Downtown Women's Health Care

    Denver, Colorado

  • Genitourinary Surgical Consultants

    Denver, Colorado

  • Connecticut Clinical Research Center, LLC

    Middlebury, Connecticut

  • South Florida Medical Research

    Aventura, Florida

  • Women's Medical Research Group, LLC

    Clearwater, Florida

  • Medsearch Professional Group

    Miami, Florida

  • Sunrise Medical Research

    Plantation, Florida

  • Radiant Research

    Stuart, Florida

  • Southeastern Research Group, Inc.

    Tallahassee, Florida

  • Tampa Bay Urology

    Tampa, Florida

  • Radiant Research

    West Palm Beach, Florida

  • Southeastern Medical Research Institute

    Columbus, Georgia

  • Investigational site - PC

    Dunwoody, Georgia

  • Accelovance

    Peoria, Illinois

  • Radiant Research, Kansas City

    Overland Park, Kansas

  • Benchmark Research

    Metairie, Louisiana

  • Regional Urology, LLC

    Shreveport, Louisiana

  • Pierremont Women's Clinic

    Shreveport, Louisiana

  • FutureCare Studies, Inc.

    Springfield, Massachusetts

  • Radiant Research Inc.

    St Louis, Missouri

  • Women's Clinic of Lincoln, P.C

    Lincoln, Nebraska

  • Investigational site

    Las Vegas, Nevada

  • AdvanceMed Research

    Lawrenceville, New Jersey

  • Lawrenceville Urology

    Lawrenceville, New Jersey

  • Morristown Urology

    Morristown, New Jersey

  • Urology Group of New Mexico, PC

    Albuquerque, New Mexico

  • Upstate Urology

    Albany, New York

  • Investigational site - Adult & Pediatric Urology

    Carmel, New York

Showing 40 of 80 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.